Tradestie Institutional Equity Comparison Engine

MTNB vs LCTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LCTX Overall Edge

LCTX Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Lineage Cell Therapeutics, Inc. (LCTX) driven by superior Valuation, Growth & Margin while MTNB counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus LCTX at 30.7x Forward P/E and -280.3% operating margin (-61.0% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LCTX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LCTX
MTNB N/M vs LCTX 30.7x Fwd P/E
Growth & Margin Winner LCTX
Op Margin 0.0% vs -280.3% ยท YoY -100.0% vs -61.0%
Momentum & Technical Winner MTNB
1Y -31.4% vs -53.7% ยท 52W Pos 22% vs 4%
Options & Structure Winner MTNB
UNCLASSIFIED (N/A IV) vs BREAKDOWN (100th %ile IV)
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0
LCTX NYSE American
Lineage Cell Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$0.82
-2.21% 1D
Market Cap $212.1M
1M Return -13.82%
1Y Return -53.67%
Forward P/E 30.7x
Unified AI Score
58.9 / 100 HOLD
Tech 65.0 Fund 54.0 Flow 65.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTNB -31.35% LCTX -53.67% Spread: +22.32 pp (MTNB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MTNB Revenue LCTX Revenue MTNB Op. Margin LCTX Op. Margin Margin Edge
FY2018 $0M $0M -12230.9% -837.9% LCTX
FY2019 $0M $0M -21067.4% -1106.0% LCTX
FY2020 $0M $0M -15288.4% -1448.4% LCTX
FY2021 $0M $0M -74954.5% -1133.6% LCTX
FY2022 $0M $10M -771.3% -153.2% LCTX
FY2023 $0M $10M -2168.4% -276.5% LCTX
FY2024 N/A $10M N/A -226.1% LCTX
FY2025 N/A $10M N/A -251.6% LCTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTNB (2) vs LCTX (8)
Institutional Metric MTNB LCTX Criterion Row Winner
Market Capitalization Scale $979,904 $212.1M Larger Scale LCTX
Trailing P/E Ratio Valuation N/M 30.7x Lower Multiple LCTX
Forward P/E Ratio Valuation N/M 30.7x Lower Multiple LCTX
Revenue Growth (YoY) Growth -100.0% -61.0% Higher Growth LCTX
Operating Margin (TTM) Profitability 0.0% -280.3% Higher Margin MTNB
Net Profit Margin Profitability 0.0% 16.2% Higher Margin LCTX
Return on Equity (ROE) Capital Efficiency -147.5% 4.3% Higher ROE LCTX
52-Week Range Position Momentum 22% ($0โ€“$3) 4% ($1โ€“$2) Stronger Trend MTNB
Beta / 30D Volatility Risk Regime -7.20ฮฒ ยท 147% Vol 1.36ฮฒ ยท 79% Vol Lower Realized Risk LCTX
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 58.9 / 100 (HOLD) Higher Composite LCTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTNB vs LCTX Buy Guide
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LCTX BREAKDOWN
6d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live LCTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTNB nor LCTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.